Chriskott Todd is currently an Associate Director at Berkadia, specializing in multifamily investment properties across Idaho and Montana. Previously, they worked as a Research Associate at Shoreline Biosciences, Inc., where they developed iPSC-derived NK and Macrophage cell therapies for cancer targeting. In 2022, they also served as an Analyst at Primrose Real Estate, focusing on mobile home community analysis on the West Coast. Chriskott is pursuing a Bachelor of Science in Biology-Chemistry at Point Loma Nazarene University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices